Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease

Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease

(2017) Ismael Huertas et al.   PLoS One

Epigenetic regulation in Parkinson’s disease

(2016) Catherine Labbé et al.   ACTA NEUROPATHOLOGICA

The epidemiology of Parkinson's disease: risk factors and prevention

(2016) Alberto Ascherio et al.   LANCET NEUROLOGY

Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression

(2016) Frank Soldner et al.   NATURE

Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression

(2016) Albert A. Davis et al.   NEUROBIOLOGY OF AGING

Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease

(2016) Gang Wang et al.   PARKINSONISM & RELATED DISORDERS

Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease

(2016) Marie Y. Davis et al.   JAMA Neurology

Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype

(2016) Christine A. Cooper et al.   Annals of Clinical and Translational Neurology

Polygenic risk of Parkinson disease is correlated with disease age at onset

(2015) Valentina Escott-Price et al.   ANNALS OF NEUROLOGY

Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

(2015) Melissa E. Murray et al.   BRAIN

Cumulative genetic risk and age at onset in Parkinson's disease

(2015) Lasse Pihlstrøm et al.   MOVEMENT DISORDERS

PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease

(2015) G. W. Beecham et al.   NEUROLOGY

Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease

(2014) Anna Oczkowska et al.   CURRENT GENOMICS

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

(2014) Mike A Nalls et al.   NATURE GENETICS

ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

(2014) Takahisa Kanekiyo et al.   NEURON

Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

(2013) Jeffrey H. Kordower et al.   BRAIN

Genomics and Bioinformatics of Parkinson's Disease

(2013) S. W. Scholz et al.   Cold Spring Harbor Perspectives in Medicine

Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010

(2012) Thomas G. Beach et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease

(2012) Beate Ritz et al.   PLoS One

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Clinical progression in Parkinson disease and the neurobiology of axons

(2010) Hsiao-Chun Cheng et al.   ANNALS OF NEUROLOGY

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

(2009) Dennis W Dickson et al.   LANCET NEUROLOGY

Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles

(2009) D. A. Bennett et al.   NEUROLOGY

Evaluation of α-synuclein immunohistochemical methods used by invited experts

(2008) Thomas G. Beach et al.   ACTA NEUROPATHOLOGICA

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease

(2008) Dennis W. Dickson et al.   ACTA NEUROPATHOLOGICA

Incidental Lewy Body Disease and Preclinical Parkinson Disease

(2008) Anthony DelleDonne et al.   ARCHIVES OF NEUROLOGY